(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.81%) $83.17
(-1.16%) $1.619
(-0.43%) $2 337.00
(-0.04%) $27.24
(0.64%) $928.00
(-0.17%) $0.933
(-0.12%) $11.01
(-0.23%) $0.799
(0.00%) $92.17
Quarter results tomorrow
(bmo 2024-04-30)
Expected move: +/- 4.25%
0.45% INR 1 574.25
Live Chart Being Loaded With Signals
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally...
Stats | |
---|---|
Tagesvolumen | 1 726.00 |
Durchschnittsvolumen | 20 441.00 |
Marktkapitalisierung | 26.04B |
EPS | INR0 ( 2024-04-26 ) |
Nächstes Ertragsdatum | ( INR0 ) 2024-04-30 |
Last Dividend | INR12.00 ( 2023-07-21 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 30.72 |
ATR14 | INR1.645 (0.11%) |
Volumen Korrelation
RPG Life Sciences Limited Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
RPG Life Sciences Limited Korrelation - Währung/Rohstoff
RPG Life Sciences Limited Finanzdaten
Annual | 2022 |
Umsatz: | INR5.13B |
Bruttogewinn: | INR3.42B (66.68 %) |
EPS: | INR40.90 |
FY | 2022 |
Umsatz: | INR5.13B |
Bruttogewinn: | INR3.42B (66.68 %) |
EPS: | INR40.90 |
FY | 2022 |
Umsatz: | INR4.37B |
Bruttogewinn: | INR2.87B (65.64 %) |
EPS: | INR31.13 |
FY | 2021 |
Umsatz: | INR3.83B |
Bruttogewinn: | INR2.46B (64.10 %) |
EPS: | INR24.19 |
Financial Reports:
No articles found.
RPG Life Sciences Limited Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR9.60 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR12.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR1.200 | 2008-08-11 |
Last Dividend | INR12.00 | 2023-07-21 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 16 | -- |
Total Paid Out | INR51.04 | -- |
Avg. Dividend % Per Year | 1.03% | -- |
Score | 2.26 | -- |
Div. Sustainability Score | 3.08 | |
Div.Growth Potential Score | 4.87 | |
Div. Directional Score | 3.97 | -- |
Year | Amount | Yield |
---|---|---|
2008 | INR0 | 0.00% |
2009 | INR0 | 0.00% |
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR2.40 | 0.61% |
2019 | INR2.40 | 1.01% |
2020 | INR4.00 | 1.26% |
2021 | INR7.20 | 1.92% |
2022 | INR9.60 | 1.57% |
2023 | INR12.00 | 1.41% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
KRBL.NS | Dividend Junior | 2023-08-25 | Annually | 23 | 0.61% | |
FCL.NS | Dividend Junior | 2023-09-08 | Annually | 10 | 0.22% | |
ANANTRAJ.NS | Dividend Junior | 2023-06-27 | Annually | 18 | 0.22% | |
TATACOFFEE.NS | Dividend Junior | 2023-05-15 | Annually | 23 | 0.85% | |
NIACL.NS | No Dividend Player | 2023-09-07 | Sporadic | 7 | 0.44% | |
INDIAGLYCO.NS | Dividend Junior | 2023-09-05 | Sporadic | 20 | 0.85% | |
CHOLAHLDNG.NS | Dividend Junior | 2023-08-03 | Annually | 23 | 0.06% | |
SANDHAR.NS | Dividend Junior | 2023-09-14 | Annually | 7 | 0.66% | |
LXCHEM.NS | Dividend Junior | 2023-07-20 | Annually | 4 | 0.11% | |
GLENMARK.NS | Dividend Junior | 2023-09-18 | Annually | 23 | 0.37% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.148 | 1.500 | 7.04 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.264 | 1.500 | 8.18 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 309.81 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 19.92 | 2.00 | 3.36 | 6.72 | [0 - 30] |
freeCashFlowPerShareTTM | 19.92 | 2.00 | 0.0418 | 0.0835 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.617 | 1.000 | 3.05 | 3.05 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.194 | 1.000 | 8.11 | 8.11 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 3.08 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 30.58 | 1.000 | 7.01 | 0 | [1 - 100] |
returnOnEquityTTM | 0.264 | 2.50 | 8.83 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 19.92 | 2.00 | 3.36 | 0.0835 | [0 - 30] |
dividendYielPercentageTTM | 0.766 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 19.92 | 2.00 | 3.36 | 6.72 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 1.066 | 1.500 | 6.23 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0574 | 1.000 | -1.064 | 0 | [0.1 - 0.5] |
Total Score | 4.87 |
RPG Life Sciences Limited
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, anti-spasmodic, etc. It also provides generics primarily in area of immunosuppressant therapy; and finished dosage formulations for various therapies, such as nephrology, rheumatology, oncology, gastroenterology, cardiovascular, diabetology, orthopedics, neuropsychiatry, respiratory, nutritional, general, urology, anti-diabetic, anti-dengue, vitamins and minerals, gynecology and pediatrics, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.